Browse the detailed record of transactions filed by 周伟, Cadre. Insider active across 2 companies, notably 新天药业. Cumulatively, 16 reports have been recorded. Regulator: AMF. The full history is free.
Declarations 16 total
Executives ● Sale新 新天药业 22 SZSE 2,190,500 shares
SZSE:273000000052638400 · 18 Dec 2025
Executives ● Purchase兰 兰州银行 7 SZSE 5,000 shares
SZSE:173000008572407460 · 18 Feb 2025
Ideal exit: 15 Nov 2025 (T+270) Executives ● Purchase兰 兰州银行 7 SZSE 21,000 shares
SZSE:173000008467691420 · 20 Jan 2025
Ideal exit: 17 Oct 2025 (T+270) Executives ● Purchase兰 兰州银行 7 SZSE 60,000 shares
SZSE:173000008463045280 · 17 Jan 2025
Ideal exit: 14 Oct 2025 (T+270) Executives ● Purchase兰 兰州银行 7 SZSE 10,000 shares
SZSE:173000008402299550 · 3 Jan 2025
Ideal exit: 30 Sept 2025 (T+270) Executives ● Purchase兰 兰州银行 7 SZSE 29,000 shares
SZSE:173000006275045150 · 13 Feb 2023
Ideal exit: 10 Nov 2023 (T+270) Executives ● Purchase兰 兰州银行 11 SZSE 33,100 shares
SZSE:173000006251051070 · 1 Feb 2023
Ideal exit: 29 Oct 2023 (T+270) Executives ● Sale新 新天药业 11 SZSE 12,000 shares
SZSE:173000006007403000 · 2 Nov 2022
Executives ● Sale新 新天药业 7 SZSE 3,400 shares
SZSE:173000005962873100 · 19 Oct 2022
Executives ● Sale新 新天药业 11 SZSE 46,000 shares
SZSE:173000005962890800 · 19 Oct 2022
Executives ● Sale新 新天药业 7 SZSE 19,400 shares
SZSE:173000005962873570 · 19 Oct 2022
Executives ● Sale新 新天药业 11 SZSE 8,000 shares
SZSE:173000005962873540 · 19 Oct 2022
Executives ● Sale新 新天药业 11 SZSE 16,000 shares
SZSE:173000005962873470 · 19 Oct 2022
Executives ● Sale新 新天药业 7 SZSE 252,000 shares
SZSE:173000005962873400 · 19 Oct 2022
Executives ● Sale新 新天药业 7 SZSE 3,500 shares
SZSE:173000005962873200 · 19 Oct 2022
Executives ● Purchase兰 兰州银行 7 SZSE 500 shares
SZSE:173000005339583970 · 11 Jan 2022
Ideal exit: 8 Oct 2022 (T+270) About 周伟 Zhou Wei is an executive and supervisor at新天药业 and兰州银行. He plays a key role in managing operations and overseeing governance practices. His expertise in the banking and pharmaceutical sectors allows him to provide valuable insights to enhance the performance of both companies.